AJP - Heart Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 285: H669-H678, 2003. First published April 3, 2003; doi:10.1152/ajpheart.01025.2002
0363-6135/03 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
285/2/H669    most recent
01025.2002v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via ISI Web of Science (32)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Venema, R. C.
Right arrow Articles by Catravas, J. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Venema, R. C.
Right arrow Articles by Catravas, J. D.

Novel complexes of guanylate cyclase with heat shock protein 90 and nitric oxide synthase

Richard C. Venema,1,2,3 Virginia J. Venema,1 Hong Ju,1 M. Brennan Harris,1 Connie Snead,1 Tamas Jilling,4 Christiana Dimitropoulou,3 Michael E. Maragoudakis,1 and John D. Catravas1,3

1Vascular Biology Center, 2Department of Pediatrics, and 3Department of Pharmacology and Toxicology, Medical College of Georgia, Augusta, Georgia 30912-2500; and 4Department of Pediatrics, Feinberg School of Medicine, Northwestern University, Chicago, Illinois 60611-3008

Submitted 2 December 2002 ; accepted in final form 1 April 2003

Soluble guanylate cyclase (sGC) is an important downstream intracellular target of nitric oxide (NO) that is produced by endothelial NO synthase (eNOS) and inducible NO synthase (iNOS). In this study, we demonstrate that sGC exists in a complex with eNOS and heat shock protein 90 (HSP90) in aortic endothelial cells. In addition, we show that in aortic smooth muscle cells, sGC forms a complex with HSP90. Formation of the sGC/eNOS/HSP90 complex is increased in response to eNOS-activating agonists in a manner that depends on HSP90 activity. In vitro binding assays with glutathione S-transferase fusion proteins that contain the {alpha}- or {beta}-subunit of sGC show that the sGC {beta}-subunit interacts directly with HSP90 and indirectly with eNOS. Confocal immunofluorescent studies confirm the subcellular colocalization of sGC and HSP90 in both endothelial and smooth muscle cells. Complex formation of sGC with HSP90 facilitates responses to NO donors in cultured cells (cGMP accumulation) as well as in anesthetized rats (hypotension). These complexes likely function to stabilize sGC as well as to provide directed intracellular transfer of NO from NOS to sGC, thus preventing inactivation of NO by superoxide anion and formation of peroxynitrite, which is a toxic molecule that has been implicated in the pathology of several vascular diseases.

smooth muscle cells; endothelium; vascular endothelial growth factor; bradykinin; cGMP accumulation



Address for reprint requests and other correspondence: J. D. Catravas, Vascular Biology Center, Medical College of Georgia, Augusta, Georgia 30912-2500 (E-mail: jcatrava{at}mail.mcg.edu).







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2003 by the American Physiological Society.